X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
psychiatry (52) 52
humans (39) 39
index medicus (39) 39
female (34) 34
bipolar disorder (33) 33
male (33) 33
adult (26) 26
clinical neurology (23) 23
middle aged (23) 23
bipolar disorder - psychology (18) 18
mania (18) 18
internal medicine (17) 17
neurosciences (17) 17
bipolar disorder - diagnosis (13) 13
bipolar disorder - drug therapy (13) 13
follow-up studies (13) 13
rating-scale (12) 12
depression (11) 11
schizophrenia (11) 11
lithium (9) 9
antipsychotic agents - therapeutic use (8) 8
psychiatric status rating scales (8) 8
psychology (8) 8
treatment outcome (8) 8
bipolar disorder - epidemiology (7) 7
efficacy (7) 7
pharmacology & pharmacy (7) 7
aged (6) 6
diagnostic and statistical manual of mental disorders (6) 6
double-blind (6) 6
mood disorders (6) 6
neuropsychological tests (6) 6
risk factors (6) 6
symptoms (6) 6
antimanic agents - therapeutic use (5) 5
double-blind method (5) 5
hospitalization (5) 5
proportional hazards models (5) 5
psychoeducation (5) 5
psychology, clinical (5) 5
secondary prevention (5) 5
antidepressive agents - therapeutic use (4) 4
brain (4) 4
cardiovascular diseases (4) 4
cardiovascular diseases - prevention & control (4) 4
care and treatment (4) 4
cognition disorders - epidemiology (4) 4
cognitive impairment (4) 4
comorbidity (4) 4
cross-sectional studies (4) 4
diabetes mellitus, type 2 - drug therapy (4) 4
drug therapy, combination (4) 4
follow-up (4) 4
insulin (4) 4
insulin glargine (4) 4
maintenance treatment (4) 4
memory (4) 4
mental disorders (4) 4
neuroimaging (4) 4
prospective studies (4) 4
psychosis (4) 4
reliability (4) 4
risperidone (4) 4
severity of illness index (4) 4
single-blind method (4) 4
validity (4) 4
abridged index medicus (3) 3
affective-disorder (3) 3
antipsychotics (3) 3
bipolar disorder - physiopathology (3) 3
bipolar disorder - prevention & control (3) 3
bipolar disorder - therapy (3) 3
cardiovascular disease (3) 3
case-control studies (3) 3
cholesterol (3) 3
clinical trial (3) 3
complications and side effects (3) 3
diabetes (3) 3
diabetes mellitus, type 2 - complications (3) 3
dibenzothiazepines - therapeutic use (3) 3
disability (3) 3
dose-response relationship, drug (3) 3
fatty acids (3) 3
functional impairment (3) 3
functional outcome (3) 3
haloperidol (3) 3
hospitalization - statistics & numerical data (3) 3
i disorder (3) 3
impairment (3) 3
insulin, long-acting (3) 3
medical research (3) 3
monotherapy (3) 3
neuropsychology (3) 3
outcome (3) 3
patient education as topic (3) 3
prevention (3) 3
prophylaxis (3) 3
psychosocial functioning (3) 3
psychotherapy (3) 3
quetiapine fumarate (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Heart Journal, ISSN 0002-8703, 2008, Volume 155, Issue 1, pp. 26.e1 - 26.e13
Journal Article
by Hibar, D.P and Westlye, L.T and Doan, N.T and Jahanshad, N and Cheung, J.W and Ching, C.R.K and Versace, A and Bilderbeck, A.C and Uhlmann, A and Mwangi, B and Krämer, B and Overs, B and Hartberg, C.B and Abe, C and Dima, D and Grotegerd, D and Sprooten, E and Ben, E and Jimenez, E and Howells, F.M and Delvecchio, G and Temmingh, H and Starke, J and Almeida, J.R.C and Goikolea, J.M and Houenou, J and Beard, L.M and Rauer, L and Abramovic, L and Bonnin, M and Ponteduro, M.F and Keil, M and Rive, M.M and Yao, N and Yalin, N and Najt, P and Rosa, P.G and Redlich, R and Trost, S and Hagenaars, S and Fears, S.C and Alonso-Lana, S and Van Erp, T.G.M and Nickson, T and Chaim-Avancini, T.M and Meier, T.B and Elvsashagen, T and Haukvik, U.K and Lee, W.H and Schene, A.H and Lloyd, A.J and Young, A.H and Nugent, A and Dale, A.M and Pfennig, A and McIntosh, A.M and Lafer, B and Baune, B.T and Ekman, C.J and Zarate, C.A and Bearden, C.E and Henry, C and Simhandl, C and McDonald, C and Bourne, C and Stein, D.J and Wolf, D.H and Cannon, D.M and Glahn, D.C and Veltman, D.J and Pomarol-Clotet, E and Vieta, E and Canales-Rodriguez, E.J and Nery, F.G and Duran, F.L.S and Busatto, G.F and Roberts, G and Pearlson, G.D and Goodwin, G.M and Kugel, H and Whalley, H.C and Ruhe, H.G and Soares, J.C and Fullerton, J.M and Rybakowski, J.K and Savitz, J and Chaim, K.T and Fatjó-Vilas, M and Soeiro-De-Souza, M.G and Boks, M.P and Zanetti, M.V and Otaduy, M.C.G and Schaufelberger, M.S and Alda, M and Ingvar, M and Phillips, M.L and Kempton, M.J and Bauer, M and Landén, M and Lawrence, N.S and ... and ENIGMA Bipolar Disorder Working and for the ENIGMA Bipolar Disorder Working Group and Institute of Neuroscience and Physiology and Sahlgrenska akademin and Göteborgs universitet and Gothenburg University and Sahlgrenska Academy and Institutionen för neurovetenskap och fysiologi
Molecular Psychiatry, ISSN 1359-4184, 04/2018, Volume 23, Issue 4, pp. 932 - 942
Journal Article
European Neuropsychopharmacology, ISSN 0924-977X, 2014, Volume 24, pp. S490 - S491
Journal Article
by Gerstein, Hertzel C and Bosch, Jackie and Dagenais, Gilles R and Díaz, Rafael and Jung, Hyejung and Maggioni, Aldo P and Pogue, Janice and Probstfield, Jeffrey and Ramachandran, Ambady and Riddle, Matthew C and Rydén, Lars E and Yusuf, Salim and Richardson, L and Diaz, R and Johnston, P and Vige, R and Birkeland, K and Budaj, A and Cardona, E and Chazova, I and Commerford, P and Danilova, L and Davies, M and Fernando, R and Fodor, G and Gilbert, R and Gomis, R and Hâncu, N and Hanefeld, M and Hildebrandt, P and Kacerovsky-Bielesz, G and Keltai, M and Kim, J.H and Krum, H and Kültürsay, H and Lanas, F and Lewis, B.S and Lonn, E and López-Jaramillo, P and Marin-Neto, J and Marre, M and McKelvie, R and McQueen, M and Mendoza, I and Morillo, C and Pan, C and Pīrāgs, V and Profozic, V and Ratner, R and Richardson, L and Rosenstock, J and Spinas, G.A and Sreenan, S and Stoel, I and Syvänne, M and Yale, J.F and Avezum, A and Bahit, M.C and Bogaty, P and Bordeleau, L and Chacόn, C and Corson, M and Harper, W.L and Halon, D and Magloire, P and Mann, J and Pavlova, V and Punthakee, Z and Silva, J and Tsang, B and Yakubovich, N and Abdallah, A and Ahmad, S and Chandra, J and Chandra, R and Cukierman-Yaffee, T and Dyal, L and Joldersma, L and MacRae, L and MacRae, S and Malik, S and Mead, A and Pasha, F and Pazmino-Canizares, J and Pohl, K and Sakalas, A and Tyrwhitt, J and Ahuad Guerrero, R and Alebuena, A and Alvarez, N and Alzogaray, M and Amuchastegui, M and Andres, M and Angos, M and Baglivo, H and Barbieri, M and Bassi, F and Bello, F and Bono, J and Bustamante Labarta, M and ... and The ORIGIN Trial Investigators and ORIGIN Trial Investigators and Medicinska och farmaceutiska vetenskapsområdet and Uppsala universitet and Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm and Centrum för klinisk forskning, Västerås
The New England Journal of Medicine, ISSN 0028-4793, 07/2012, Volume 367, Issue 4, pp. 319 - 328
In this study with a 2-by-2 factorial design, patients with cardiovascular risk factors and dysglycemia or type 2 diabetes received insulin glargine or... 
DIABETES-MELLITUS | MEDICINE, GENERAL & INTERNAL | GLYCEMIC CONTROL | THERAPY | GLARGINE | GLUCOSE CONTROL | DISEASE | RISK | PEOPLE | ENDOTHELIAL FUNCTION | BETA-CELL FUNCTION | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Cholesterol - blood | Humans | Middle Aged | Male | Incidence | Glucose Intolerance - drug therapy | Cardiovascular Diseases - epidemiology | Female | Drug Therapy, Combination | Hypoglycemia - chemically induced | Diabetes Mellitus, Type 2 - complications | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Fasting | Blood Glucose - analysis | Double-Blind Method | Proportional Hazards Models | Hospitalization | Glucose Intolerance - complications | Insulin, Long-Acting - adverse effects | Insulin Glargine | Insulin, Long-Acting - therapeutic use | Intention to Treat Analysis | Triglycerides - blood | Fatty Acids, Omega-3 - therapeutic use | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Complications and side effects | Care and treatment | Insulin glargine | Patient outcomes | Causes of | Cardiovascular diseases | Risk factors | Myocardial infarction | Fees & charges | Cerebral infarction | Medical research | Stroke | Heart attacks | Statistical analysis | Diabetes mellitus | Glucose | Hypoglycemia | Fatty acids | Insulin | Glucose tolerance | Insulin resistance | Microvasculature | Diabetes | Diabetes mellitus (non-insulin dependent) | Heart diseases | Drug dosages | Index Medicus | Abridged Index Medicus | Cardiovascular Diseases | Insulin, Long-Acting | Blood Glucose | Triglycerides | Glucose Intolerance | Cholesterol | Life Sciences | Hypoglycemic Agents | Diabetes Mellitus, Type 2 | Fatty Acids, Omega-3 | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article